Learn More
Invitrogen™ DPT Polyclonal Antibody

Description
Recommended positive controls: Dermatopontin tansfected 293T cell. Predicted reactivity: Rat (93%), Xenopus laevis (81%), Dog (95%), Bovine (96%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | DPT |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.53 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 |
| Gene | DPT |
| Gene Accession No. | Q07507 |
| Gene Alias | 1810032B19Rik; 22 kDa extracellular matrix protein; 5033416F05Rik; Dermatan sulfate proteoglycan-associated protein 22K; dermatopontin; Dpt; Early quiescence protein 1; early quiescence protein-1; Eq1; EQ-1; hypothetical protein LOC555282; si:dkey-98p3.2; similar to Dermatopontin precursor (Tyrosine-rich acidic matrix protein) (TRAMP); TRAMP; Tyrosine-rich acidic matrix protein; zgc:136613 |
| Gene Symbols | DPT |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.